DOCSLIB.ORG

Induced DNA Damage, Mutagenesis, and Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Induced DNA Damage, Mutagenesis, and Cancer International Journal of Molecular Sciences Chemically- Induced DNA Damage, Mutagenesis, and Cancer Edited by Ashis K. Basu and Takehiko Nohmi Printed Edition of the Special Issue Published in IJMS www.mdpi.com/journal/ijms Chemically-Induced DNA Damage, Mutagenesis, and Cancer Chemically-Induced DNA Damage, Mutagenesis, and Cancer Special Issue Editors Ashis K. Basu Takehiko Nohmi MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Ashis K. Basu Takehiko Nohmi University of Connecticut National Institute of Health Sciences USA Japan Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal International Journal of Molecular Sciences (ISSN 1422-0067) from 2017 to 2018 (available at: http:// www.mdpi.com/journal/ijms/special issues/chemical induced mutagenesis) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-129-0 (Pbk) ISBN 978-3-03897-130-6 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Contents About the Special Issue Editors ..................................... vii Preface to ”Chemically-Induced DNA Damage, Mutagenesis, and Cancer” ............ ix Ashis K. Basu DNA Damage, Mutagenesis and Cancer Reprinted from: Int. J. Mol. Sci. 2018, 19, 970, doi: 10.3390/ijms19040970 .............. 1 Peter W. Villalta and Silvia Balbo The Future of DNA Adductomic Analysis Reprinted from: Int. J. Mol. Sci. 2017, 18, 1870, doi: 10.3390/ijms18091870 .............. 14 Riccardo Miggiano, Anna Valenti, Franca Rossi, Menico Rizzi, Giuseppe Perugino and Maria Ciaramella Every OGT Is Illuminated ... by Fluorescent and Synchrotron Lights Reprinted from: Int. J. Mol. Sci. 2017, 18, 2613, doi: 10.3390/ijms18122613 .............. 34 Anna Kakehashi, Naomi Ishii, Takahiro Okuno, Masaki Fujioka, Min Gi and Hideki Wanibuchi Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis Reprinted from: Int. J. Mol. Sci. 2017, 18, 1801, doi: 10.3390/ijms18081801 .............. 52 Elizaveta O. Boldinova, Paulina H. Wanrooij, Evgeniy S. Shilkin, Sjoerd Wanrooij and Alena V. Makarova DNA Damage Tolerance by Eukaryotic DNA Polymerase and Primase PrimPol Reprinted from: Int. J. Mol. Sci. 2017, 18, 1584, doi: 10.3390/ijms18071584 .............. 69 Neenu Singh, Bryant C. Nelson, Leona D. Scanlan, Erdem Coskun, Pawel Jaruga and Shareen H. Doak Exposure to Engineered Nanomaterials: Impact on DNA Repair Pathways Reprinted from: Int. J. Mol. Sci. 2017, 18, 1515, doi: 10.3390/ijms18071515 .............. 83 Filippo Cellai, Armelle Munnia, Jessica Viti, Saer Doumett, Costanza Ravagli, Elisabetta Ceni, Tommaso Mello, Simone Polvani, Roger W. Giese, Giovanni Baldi, Andrea Galli and Marco E. M. Peluso Magnetic Hyperthermia and Oxidative Damage to DNA of Human Hepatocarcinoma Cells Reprinted from: Int. J. Mol. Sci. 2017, 18, 939, doi: 10.3390/ijms18050939 .............. 98 Jeong-Hyeon Ko, Gautam Sethi, Jae-Young Um, Muthu K Shanmugam, Frank Arfuso, Alan Prem Kumar, Anupam Bishayee and Kwang Seok Ahn The Role of Resveratrol in Cancer Therapy Reprinted from: Int. J. Mol. Sci. 2017, 18, 2589, doi: 10.3390/ijms18122589 ..............113 Hong-Mei Yang, Chao-Yue Sun, Jia-Li Liang, Lie-Qiang Xu, Zhen-Biao Zhang, Dan-Dan Luo, Han-Bin Chen, Yong-Zhong Huang, Qi Wang, David Yue-Wei Lee, Jie Yuan and Yu-Cui Li Supercritical-Carbon Dioxide Fluid Extract from Chrysanthemum indicum Enhances Anti-Tumor Effect and Reduces Toxicity of Bleomycin in Tumor-Bearing Mice Reprinted from: Int. J. Mol. Sci. 2017, 18, 465, doi: 10.3390/ijms18030465 ..............149 v Razmik Mirzayans, Bonnie Andrais, Piyush Kumar and David Murray Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome Reprinted from: Int. J. Mol. Sci. 2017, 19, 928, doi: 10.3390/ijms18050928 ..............164 Tze-An Yuan, Vandy Yourk, Ali Farhat, Argyrios Ziogas, Frank L. Meyskens, Hoda Anton-Culver and Feng Liu-Smith A Case-Control Study of the Genetic Variability in Reactive Oxygen Species—Metabolizing Enzymes in Melanoma Risk Reprinted from: Int. J. Mol. Sci. 2018, 19, 242, doi: 10.3390/ijms19010242 ..............184 Xiali Zhong, Xing Yi, Rita de C´assia da Silveira e S´a, Yujing Zhang, Kaihua Liu, Fang Xiao and Caigao Zhong CoQ10 Deficiency May Indicate Mitochondrial Dysfunction in Cr(VI) Toxicity Reprinted from: Int. J. Mol. Sci. 2017, 18, 816, doi: 10.3390/ijms18040816 ..............202 Guochao Liu, Hui Wang, Fengmei Zhang, Youjia Tian, Zhujun Tian, Zuchao Cai, David Lim and Zhihui Feng The Effect of VPA on Increasing Radiosensitivity in Osteosarcoma Cells and Primary-Culture Cells from Chemical Carcinogen-Induced Breast Cancer in Rats Reprinted from: Int. J. Mol. Sci. 2017, 18, 1027, doi: 10.3390/ijms18051027 ..............222 Markus Wirth, Daniel Jira, Armin Ott, Guido Piontek and Anja Pickhard High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC Reprinted from: Int. J. Mol. Sci. 2018, 19, 830, doi: 10.3390/ijms19030830 ..............235 Suleva Povea-Cabello, Manuel Oropesa-Avila,´ Patricia de la Cruz-Ojeda, Marina Villanueva-Paz, Mario de la Mata, Juan Miguel Su´arez-Rivero, M´onica Alvarez-C´´ ordoba, Irene Villal´on-Garc´ıa, David Cot´an, Patricia Ybot-Gonz´alez and Jos´eA.S´anchez-Alc´azar Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis Reprinted from: Int. J. Mol. Sci. 2017, 18, 2393, doi: 10.3390/ijms18112393 ..............248 vi About the Special Issue Editors Ashis Basu, Ph.D., is Professor of Chemistry at the University of Connecticut. The research focus of the Basu laboratory is the determination of the consequences of DNA damaged by anti-tumor drugs, chemical carcinogens, oxidation, or radiation. This research at the interface of chemistry and biology involves the introduction of specific lesions in DNA by organic synthesis, investigation of the structural effects of the lesions using biophysical methods, and studying their repair and replication. Takehiko Nohmi, Ph.D., became a staff scientist at the National Institute of Health Sciences (NIHS), Tokyo in 1978. He was a postdoctoral fellow/associate at the Massachusetts Institute of Technology (MIT) (1986 to 1988). After returning to Japan, he became a section chief in 1989 and the Head of the Division of Genetics and Mutagenesis, NIHS, in 2008. He developed Salmonella typhimurium YG1021 and YG1024, strains which are highly sensitive to environmental mutagens, and gpt delta transgenic mice/rats for in vivo mutagenesis. He was involved in the discovery of novel DNA polymerase DinB, a prototype of Y-family DNA polymerase. He received the JEMS award and annual award from the Japanese Environmental Mutagen Society (JEMS) in 2006 and 1992, respectively. He was the President of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS, 2013–2017). He retired from NIHS (Tokyo) in 2012 and is currently a scientist emeritus and a visiting scientist at NIHS (Tokyo). vii Preface to ”Chemically-Induced DNA Damage, Mutagenesis, and Cancer” This volume provides a snapshot of the current advances in chemical carcinogenesis. It promotes the view that DNA damage is an important first step in the process of carcinogenesis. DNA repair processes are active in every cell to correct these damages, yet the replication of damaged DNA may occur prior to repair, resulting in gene mutations and the generation of altered proteins. Mutations in an oncogene, a tumor-suppressor gene, or a gene that controls the cell cycle give rise to a clonal cell population with an advantage in proliferation. The complex process of carcinogenesis includes many such events, but has generally been considered to comprise the three main stages known as initiation, promotion, and progression, which ultimately give rise to the induction of human cancer. Fifteen articles published in a Special Issue of IJMS entitled “Chemically-Induced DNA Damage, Mutagenesis, and Cancer” provide an overview on the topic of the “consequence of DNA damage” in the context of human cancer with their challenges and highlights. The topics of the published articles cover a wide range, which include study of DNA adducts, DNA polymerase, DNA repair and repair defects, nanoparticle-induced DNA damage and cell death, metal toxicity, apoptosis, risk of melanoma, chemoprevention, a radiosensitizer for primary culture tumor cells, the signaling of a tumor suppressor gene, and an adjuvant for chemotherapy. The variety of articles published in this Special Issue underscores the diversity of this field of research. Evidently, this is only a glimpse of this very large area of research that includes thousands of active researchers working in many complementary directions to better understand the etiology of cancer and develop superior strategies for chemoprevention
Load more

Recommended publications
  • Escherichia Coli Responses to a Single DNA Adduct
    JOURNAL OF BACTERIOLOGY, Dec. 2000, p. 6598–6604 Vol. 182, No. 23 0021-9193/00/$04.00ϩ0 Copyright © 2000, American Society for Microbiology. All Rights Reserved. Escherichia coli Responses to a Single DNA Adduct GAGAN A. PANDYA,† IN-YOUNG YANG, ARTHUR P. GROLLMAN, AND MASAAKI MORIYA* Laboratory of Chemical Biology, Department of Pharmacological Sciences, SUNY at Stony Brook, Stony Brook, New York 11794-8651 Received 14 June 2000/Accepted 12 September 2000 To study the mechanisms by which Escherichia coli modulates the genotoxic effects of DNA damage, a novel system has been developed which permits quantitative measurements of various E. coli pathways involved in mutagenesis and DNA repair. Events measured include fidelity and efficiency of translesion DNA synthesis, excision repair, and recombination repair. Our strategy involves heteroduplex plasmid DNA bearing a single site-specific DNA adduct and several mismatched regions. The plasmid replicates in a mismatch repair- deficient host with the mismatches serving as strand-specific markers. Analysis of progeny plasmid DNA for linkage of the strand-specific markers identifies the pathway from which the plasmid is derived. Using this approach, a single 1,N6-ethenodeoxyadenosine adduct was shown to be repaired inefficiently by excision repair, to inhibit DNA synthesis by approximately 80 to 90%, and to direct the incorporation of correct dTMP opposite this adduct. This approach is especially useful in analyzing the damage avoidance-tolerance mechanisms. Our results also show that (i) progeny derived from the damage avoidance-tolerance pathway(s) accounts for more than 15% of all progeny; (ii) this pathway(s) requires functional recA, recF, recO, and recR genes, suggesting the mechanism to be daughter strand gap repair; (iii) the ruvABC genes or the recG gene is also required; and (iv) the RecG pathway appears to be more active than the RuvABC pathway.
    [Show full text]
  • 1 INTRODUCTION DNA Damage and Types of Repair DNA Is Subject to Various Types of Damage That Can Impair Cellular Function Leadin
    INTRODUCTION DNA damage and types of repair DNA is subject to various types of damage that can impair cellular function leading to cell death or carcinogenesis. DNA damage blocks normal cellular processes such as replication and transcription [1, 2]. Should DNA damage persist it can have catastrophic consequences for the cell and for the organism including mutagenesis, cancer, and cell death (i.e. in neurons). DNA damage may come from internal as well as external sources and is associated with various types of genetic diseases and cancers. Therefore DNA repair provides a mechanism to restore DNA nucleotide sequences to the native state. Several DNA repair pathways have been identified including base excision repair (BER), mismatch repair (MMR) and nucleotide excision repair (NER). The type of lesion will dictate which pathway is utilized for repair. For example an N7-methyl guanine residue can only be removed by BER, while a benzopyrene guanine adduct residue can only be removed by NER [3]. Nucleotide Excision Repair Nucleotide Excision Repair (NER) is a versatile DNA repair pathway because of its ability to repair a wide range of nucleotide adducts [4]. NER is responsible for the repair of bulky DNA damage lesions including cyclobutane pyrimidine dimers (CPDs) and 6-4 pyrimidine pyrimidone photoproducts (6-4PPs) caused by UV radiation [3, 5]. NER repairs platinum DNA adducts that are formed by cancer chemotherapeutic drugs such as cisplatin and carboplatin [1, 6, 7]. UV radiation and platinum compounds cause covalent linkage of adjacent thymine or guanine residues respectively. Aromatic 1 hydrocarbons, as found in cigarette smoke, cause guanine adducts that also require NER for their removal.
    [Show full text]
  • Chapter 14: Functional Genomics Learning Objectives
    Chapter 14: Functional Genomics Learning objectives Upon reading this chapter, you should be able to: ■ define functional genomics; ■ describe the key features of eight model organisms; ■ explain techniques of forward and reverse genetics; ■ discuss the relation between the central dogma and functional genomics; and ■ describe proteomics-based approaches to functional genomics. Outline : Functional genomics Introduction Relation between genotype and phenotype Eight model organisms E. coli; yeast; Arabidopsis; C. elegans; Drosophila; zebrafish; mouse; human Functional genomics using reverse and forward genetics Reverse genetics: mouse knockouts; yeast; gene trapping; insertional mutatgenesis; gene silencing Forward genetics: chemical mutagenesis Functional genomics and the central dogma Approaches to function; Functional genomics and DNA; …and RNA; …and protein Proteomic approaches to functional genomics CASP; protein-protein interactions; protein networks Perspective Albert Blakeslee (1874–1954) studied the effect of altered chromosome numbers on the phenotype of the jimson-weed Datura stramonium, a flowering plant. Introduction: Functional genomics Functional genomics is the genome-wide study of the function of DNA (including both genes and non-genic regions), as well as RNA and proteins encoded by DNA. The term “functional genomics” may apply to • the genome, transcriptome, or proteome • the use of high-throughput screens • the perturbation of gene function • the complex relationship of genotype and phenotype Functional genomics approaches to high throughput analyses Relationship between genotype and phenotype The genotype of an individual consists of the DNA that comprises the organism. The phenotype is the outward manifestation in terms of properties such as size, shape, movement, and physiology. We can consider the phenotype of a cell (e.g., a precursor cell may develop into a brain cell or liver cell) or the phenotype of an organism (e.g., a person may have a disease phenotype such as sickle‐cell anemia).
    [Show full text]
  • Mutational Signatures: Emerging Concepts, Caveats and Clinical Applications
    REVIEWS Mutational signatures: emerging concepts, caveats and clinical applications Gene Koh 1,2, Andrea Degasperi 1,2, Xueqing Zou1,2, Sophie Momen1,2 and Serena Nik-Zainal 1,2 ✉ Abstract | Whole-genome sequencing has brought the cancer genomics community into new territory. Thanks to the sheer power provided by the thousands of mutations present in each patient’s cancer, we have been able to discern generic patterns of mutations, termed ‘mutational signatures’, that arise during tumorigenesis. These mutational signatures provide new insights into the causes of individual cancers, revealing both endogenous and exogenous factors that have influenced cancer development. This Review brings readers up to date in a field that is expanding in computational, experimental and clinical directions. We focus on recent conceptual advances, underscoring some of the caveats associated with using the mutational signature frameworks and highlighting the latest experimental insights. We conclude by bringing attention to areas that are likely to see advancements in clinical applications. The concept of mutational signatures was introduced or drug therapies, in an attempt to decipher causes7–9. in 2012 following the demonstration that analy­ However, the origins of many signatures remain cryp­ sis of all substitution mutations in a set of 21 whole­ tic. Furthermore, while earlier analyses reported single genome­sequenced (WGS) breast cancers could reveal signatures, for example of UV radiation (that is, SBS7)2, consistent patterns of mutagenesis across tumours1 more recent studies reported multiple versions of these (FIG. 1a). These patterns were the physiological imprints signatures (that is, SBS7a, SBS7b, SBS7c and SBS7d)3, of DNA damage and repair processes that had occurred leading the community to question whether some find­ during tumorigenesis and could distinguish BRCA1­null ings are reflective of biology or are simply mathemat­ and BRCA2­null tumours from sporadic breast cancers.
    [Show full text]
  • Solar Ultraviolet Radiation Dosimetry and Epidemiology
    Solar Ultraviolet Radiation Dosimetry and Epidemiology Dr. Elizabeth Cahoon Earl Stadtman Investigator Radiation Epidemiology Branch Division of Cancer Epidemiology and Genetics cahoonek@mail.nih.gov DCEG Radiation Epidemiology and Dosimetry Course 2019 www.dceg.cancer.gov/RadEpiCourse Overview . Background on UV radiation (UVR) . UVR exposure assessment . Health risks . Health benefits . Summary 2 Background on UV radiation 3 Public health importance . Prevention (identify susceptible populations) . Consumer products . Medical radiation guidelines . Insights into carcinogenesis 4 Annual economic burden of skin cancer in the United States . Treatment: $8.1 billion (Guy et al., 2015) . $4.8 billion for keratinocyte carcinomas (basal and squamous cell skin cancer) . $3.3 billion for melanoma U.S. Surgeon General’s Call to Action to Prevent Skin Cancer (2014) UV radiation exposure assessment 6 http://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/electromagnetic-fields-fact-sheet 7 Solar radiation spectrum 95% of UVA: 315-400 nm 5% of UVB: 280-315 nm Individual measures of UVR . Susceptibility (light skin/hair/eye pigmentation) . Self-reported time outdoors . Outdoor/indoor occupation . Tanning bed use . Lack of sunscreen use/protective clothing . Sunburns 9 Environmental measures of UVR . Proximity to the Equator . Ambient UVR . Ground-based . Satellite-based 10 . Satellite circled Earth once a day near noontime . Validated by ground-based measurements . 10 latitude by 10 longitude global grid . Several wavelengths available Nimbus -7 Satellite (1978-1993) Satellite-based ambient UVR . Earth-sun distance . Time of year . Latitude . Column ozone . Cloud optical thickness http://toms.gsfc.nasa.gov/n7toms/nim7toms_v8.html 12 Satellite-based erythemal exposure model http://macuv.gsfc.nasa.gov/doc/erynotes.pdf UV radiation spectrum UVA: 320-400 nm 95% reaches Earth’s surface UVB: 290-320 nm 5% reaches Earth’s surface UVC: 100-290 nm 0% reaches Earth’s surface Skin erythema (reddening) response to various UVR wavelengths UVB UVA Characteristics of UVB .
    [Show full text]
  • Gene Therapy Glossary of Terms
    GENE THERAPY GLOSSARY OF TERMS A • Phase 3: A phase of research to describe clinical trials • Allele: one of two or more alternative forms of a gene that that gather more information about a drug’s safety and arise by mutation and are found at the same place on a effectiveness by studying different populations and chromosome. different dosages and by using the drug in combination • Adeno-Associated Virus: A single stranded DNA virus that has with other drugs. These studies typically involve more not been found to cause disease in humans. This type of virus participants.7 is the most frequently used in gene therapy.1 • Phase 4: A phase of research to describe clinical trials • Adenovirus: A member of a family of viruses that can cause occurring after FDA has approved a drug for marketing. infections in the respiratory tract, eye, and gastrointestinal They include post market requirement and commitment tract. studies that are required of or agreed to by the study • Adeno-Associated Virus Vector: Adeno viruses used as sponsor. These trials gather additional information about a vehicles for genes, whose core genetic material has been drug’s safety, efficacy, or optimal use.8 removed and replaced by the FVIII- or FIX-gene • Codon: a sequence of three nucleotides in DNA or RNA • Amino Acids: building block of a protein that gives instructions to add a specific amino acid to an • Antibody: a protein produced by immune cells called B-cells elongating protein in response to a foreign molecule; acts by binding to the • CRISPR: a family of DNA sequences that can be cleaved by molecule and often making it inactive or targeting it for specific enzymes, and therefore serve as a guide to cut out destruction and insert genes.
    [Show full text]
  • The Limitations of DNA Interstrand Cross-Link Repair in Escherichia Coli
    Portland State University PDXScholar Dissertations and Theses Dissertations and Theses 7-12-2018 The Limitations of DNA Interstrand Cross-link Repair in Escherichia coli Jessica Michelle Cole Portland State University Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds Part of the Biology Commons Let us know how access to this document benefits ou.y Recommended Citation Cole, Jessica Michelle, "The Limitations of DNA Interstrand Cross-link Repair in Escherichia coli" (2018). Dissertations and Theses. Paper 4489. https://doi.org/10.15760/etd.6373 This Thesis is brought to you for free and open access. It has been accepted for inclusion in Dissertations and Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: pdxscholar@pdx.edu. The Limitations of DNA Interstrand Cross-link Repair in Escherichia coli by Jessica Michelle Cole A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Biology Thesis Committee: Justin Courcelle, Chair Jeffrey Singer Rahul Raghavan Portland State University 2018 i Abstract DNA interstrand cross-links are a form of genomic damage that cause a block to replication and transcription of DNA in cells and cause lethality if unrepaired. Chemical agents that induce cross-links are particularly effective at inactivating rapidly dividing cells and, because of this, have been used to treat hyperproliferative skin disorders such as psoriasis as well as a variety of cancers. However, evidence for the removal of cross- links from DNA as well as resistance to cross-link-based chemotherapy suggests the existence of a cellular repair mechanism.
    [Show full text]
  • Scientific Communiqué Vi Ultraviolet Radiation Damage and Oxidative Stress in Skin Cancer
    SCIENTIFIC COMMUNIQUÉ VI ULTRAVIOLET RADIATION DAMAGE AND OXIDATIVE STRESS IN SKIN CANCER. October 2020 Introduction Despite government campaigns to curb increases, current statistics show the rate of skin cancer is escalating, particularly in regions with predominantly fair-skinned populations. Skin cancer diagnoses have increased considerably over the last five decades, at a rate of 4% per annum. Approximately 5.3 million individuals are diagnosed with a skin cancer in the USA annually. Two in three Australians will be diagnosed with a form of skin cancer by the age of 70. Advances in molecular genetics in recent decades have led to a better understanding of the aetiology of skin cancers, which must now be used to help combat the rise of these life- threatening conditions. Skin cancers are an abnormal growth of cells within skin tissue. As discussed in SCIENTIFIC COMMUNIQUÉ IV there are three main types of skin cancer: basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and various forms of melanoma. Common to all three is a pathogenesis which is underpinned by overexposure of skin to genotoxic agents. Ultraviolet radiation (UVR) is the major source, with increasing evidence showing that high energy visible (HEV) light is also a contributor. Both UVR and HEV light damage skin integrity, but their effect on cellular DNA is arguably the most detrimental: initiating DNA specific chemical alterations, which leave cells unstable - the preliminary step in cancer formation. The human body has evolved DNA repair systems that identify and restore these impairments, but the capacity of these DNA repair mechanisms is limited, with excessive DNA damage associated with inefficient restoration.
    [Show full text]
  • Transposon Insertion Mutagenesis in Mice for Modeling Human Cancers: Critical Insights Gained and New Opportunities
    International Journal of Molecular Sciences Review Transposon Insertion Mutagenesis in Mice for Modeling Human Cancers: Critical Insights Gained and New Opportunities Pauline J. Beckmann 1 and David A. Largaespada 1,2,3,4,* 1 Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA; pjjackso@umn.edu 2 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA 3 Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA 4 Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA * Correspondence: larga002@umn.edu; Tel.: +1-612-626-4979; Fax: +1-612-624-3869 Received: 3 January 2020; Accepted: 3 February 2020; Published: 10 February 2020 Abstract: Transposon mutagenesis has been used to model many types of human cancer in mice, leading to the discovery of novel cancer genes and insights into the mechanism of tumorigenesis. For this review, we identified over twenty types of human cancer that have been modeled in the mouse using Sleeping Beauty and piggyBac transposon insertion mutagenesis. We examine several specific biological insights that have been gained and describe opportunities for continued research. Specifically, we review studies with a focus on understanding metastasis, therapy resistance, and tumor cell of origin. Additionally, we propose further uses of transposon-based models to identify rarely mutated driver genes across many cancers, understand additional mechanisms of drug resistance and metastasis, and define personalized therapies for cancer patients with obesity as a comorbidity. Keywords: animal modeling; cancer; transposon screen 1. Transposon Basics Until the mid of 1900’s, DNA was widely considered to be a highly stable, orderly macromolecule neatly organized into chromosomes.
    [Show full text]
  • The Repertoire of Mutational Signatures in Human Cancer
    Article The repertoire of mutational signatures in human cancer https://doi.org/10.1038/s41586-020-1943-3 Ludmil B. Alexandrov1,25, Jaegil Kim2,25, Nicholas J. Haradhvala2,3,25, Mi Ni Huang4,5,25, Alvin Wei Tian Ng4,5, Yang Wu4,5, Arnoud Boot4,5, Kyle R. Covington6,7, Dmitry A. Gordenin8, Received: 18 May 2018 Erik N. Bergstrom1, S. M. Ashiqul Islam1, Nuria Lopez-Bigas9,10,11, Leszek J. Klimczak12, Accepted: 18 November 2019 John R. McPherson4,5, Sandro Morganella13, Radhakrishnan Sabarinathan10,14,15, David A. Wheeler6,16, Ville Mustonen17,18,19, PCAWG Mutational Signatures Working Group20, Published online: 5 February 2020 Gad Getz2,3,21,22,26, Steven G. Rozen4,5,23,26*, Michael R. Stratton13,26* & PCAWG Consortium24 The number of DBSs is proportional to the number of SBSs, with few exceptions Open access Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic mutational signature1. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium2 of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA), we characterized mutational signatures using 84,729,690 somatic mutations from 4,645 whole-genome and 19,184 exome sequences that encompass most types of cancer. We identifed 49 single-base-substitution, 11 doublet-base-substitution, 4 clustered-base-substitution and 17 small insertion-and-deletion signatures. The substantial size of our dataset, compared with previous analyses3–15, enabled the discovery of new signatures, the separation of overlapping signatures and the decomposition of signatures into components that may represent associated—but distinct—DNA damage, repair and/or replication mechanisms.
    [Show full text]
  • Slow Repair of Bulky DNA Adducts Along the Nontranscribed Strand of the Human P53 Gene May Explain the Strand Bias of Transversion Mutations in Cancers
    Oncogene (1998) 16, 1241 ± 1247 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers Mikhail F Denissenko1, Annie Pao2, Gerd P Pfeifer1 and Moon-shong Tang2 1Beckman Research Institute, City of Hope, Duarte, California 91010; 2University of Texas MD Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA Using UvrABC incision in combination with ligation- cancer development (Hollstein et al., 1991, 1996; Jones mediated PCR (LMPCR) we have previously shown that et al., 1991; Harris and Hollstein, 1993; Greenblatt et benzo(a)pyrene diol epoxide (BPDE) adduct formation al., 1994; Harris, 1996; Ruddon, 1995). along the nontranscribed strand of the human p53 gene is The p53 mutations found in human cancers are of highly selective; the preferential binding sites coincide various types, and occur at dierent sequences with the major mutation hotspots found in human lung (Greenblatt et al., 1994; Hollstein et al., 1996). More cancers. Both sequence-dependent adduct formation and than 200 mutated codons of the p53 gene have been repair may contribute to these mutation hotspots in identi®ed in various human cancers, and the types of tumor tissues. To test this possibility, we have extended mutations often seem to bear the signature of the our previous studies by mapping the BPDE adduct etiological agent (Greenblatt et al., 1994; Hollstein et distribution in the transcribed strand of the p53 gene and al., 1996). One of the most notable examples is lung quantifying the rates of repair for individual damaged cancer.
    [Show full text]
  • The Role of Ultraviolet Radiation and Tyrosine Stimulated Melanogenesis in the Induction of Oxidative Stress Alterations in Fair Skin Melanocytes I
    200 Experimental Oncology 31, 200–208, 2009 (December) Exp Oncol 2009 31, 4, 200–208 THE ROLE OF ULTRAVIOLET RADIATION AND TYROSINE STIMULATED MELANOGENESIS IN THE INDUCTION OF OXIDATIVE STRESS ALTERATIONS IN FAIR SKIN MELANOCYTES I. Baldea1, *, T. Mocan1, R. Cosgarea2 1Department of Physiology, 2Department of Dermatology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca 400006, Romania Background: Melanocytes are producing melanin after UV irradiation as a defense mechanism. However, UV-induced damage is involved in melanoma initiation, depending on skin phototype. Melanocytes seem to be extremely susceptible to free radicals. Their main enzymatic antioxidants are superoxide dismutase and catalase. Aim: To study how melanin synthesis modulates the activity of the oxidative stress defense enzymes and cell proliferation after UV induced cell damage. Methods: Normal human melanocyte cultures from fair skin individuals were exposed to high levels of L-tyrosine and irradiated, with 20, 30, 40 mJ/cm2 UVA, and respective UVB. Proliferation was measured using a MTS assay; viability was assessed by trypan blue exclusion dye method. Spectrophotometrical methods were used to determine total melanin content, the enzymatic activity of tyrosinase, su- peroxide dismutase and catalase. Results: Tyrosine had a negative effect on proliferation, enhanced with time elapsed. Overall, UV irradiation decreased proliferation. UVA increased proliferation relative to UVB in the cultures exposed for a longer time to high (2 mM) tyrosine concentration. There were no proliferation differences between UVA and UVB irradiation in lower tyrosine concentration exposed melanocytes. Both, UV irradiation and tyrosine increased melanogenesis. Exposure of the melanocytes to increased levels of tyrosine in medium (0.5 mM and 1 mM) and UV irradiation enhanced the activity of superoxide dismutase and catalase.
    [Show full text]